Keywords: biosante, gets, 7m, milestone, fda, oks, elestrin

BioSante gets $7M milestone as FDA OKs Elestrin

Article | 02 April 2007

Print This

Drug developer BioSante Pharmaceuticals says it is entitled to a $7.0 million payment from fellow US firm Bradley Pharmaceuticals, as a ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in